Wikidata

(Q81916869)

English

Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma

scientific article published on 01 September 2008

In more languages

Statements

title
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18764869
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18764869%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q81916869&oldid=1561082184"